Navigation Links
Global Biomaterials Market Worth US$58.1 Billion by 2014
Date:9/1/2009

WILMINGTON, Delaware, September 1 /PRNewswire/ -- According to a new market research report, 'Global biomaterials Market (2009-2014)', published by MarketsandMarkets (http://www.marketsandmarkets.com), the total global biomaterials market is expected to be worth US$58.1 billion by 2014, growing at a CAGR of 15.0% from 2009 to 2014. The U.S. market is expected to account for nearly 42% of the total revenues. The biomaterials market today has already crossed $28 billion.

Browse over 225 market data tables and in-depth TOC on global biomaterials market. Early buyers will receive 10% customization of reports http://www.marketsandmarkets.com/Market-Reports/biomaterials-market-report- 131.html

(Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)

Biomaterials are used in the human body to replace the damaged tissues and improve body functions. Advances in technology and the emergence of innovative products have enhanced the performance and applications of biomaterials. While metals and ceramics currently dominate the biomaterials market, polymers are expected to catalyze the next wave of market growth for biomaterials.

The biomaterials market is still in a growing phase, with about 100,000 heart valves, 200,000 pacemakers and 1 million orthopedic devices implanted worldwide every year. Increase in applications has increased the demand for new biomaterials from 8% to 15%. Improved patient benefits form the most important factor stimulating market growth for biomaterials. The other market drivers are increase in aging population, rising awareness, shorter product approval time, and larger application area.

While the orthopedic biomaterials market was the biggest segment in 2008 with $9.8 billion, the cardiovascular biomaterial market is estimated to be dominant segment in 2014 with an estimated $20.7 billion. The cardiovascular biomaterial market is expected to grow with a CAGR of 14.5% from 2009 to 2014 mainly due to increasing stress levels that have in turn increased the incidence of cardiac arrest.

The U.S. market is the largest geographical segment for biomaterials; and is expected to be worth $22.8 billion by 2014 with a CAGR of 13.6% from 2009 to 2014. Europe is the second largest segment and is expected to reach $17.7 billion by 2014 with a CAGR of 14.6% and the Asian market size is estimated to increase at the highest CAGR of 18.2% from the year 2009 to 2014.

This report uses the term biomaterials to refer to the materials used in the human body. The report segments the global biomaterial market as follows:

Biomaterials product market

Orthopaedic, cardiovascular, gastrointestinal, wound care, plastic surgery, urological surgery, and others

Biomaterials ingredient market

Metals, polymers, ceramics, composites

Biomaterials application market

General, surgical appliances and supplies, surgical and medical instruments, dental products, electro-medical equipment, in-vitro diagnostic products, and other applications

Analyst Briefings on 16th Sep 2009.

The Biotech practice at MarketsandMarkets is pleased to announce its Analyst Briefing Presentation on the Global Biomaterial market to be held on 16th Sep 2009. The briefing on the Global Biomaterial Market (2009-2014) will benefit the biotech component manufacturers, biomaterial device manufacturers, medical/pharma associations, pharma research labs, Doctors, physician and hospitals, technology providers and research laboratories.

To register your participation, please click here http://www.marketsandmarkets.com/AnalystBriefing/analyst-briefing-global- biomaterial-market.asp

(Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)

Contact our representative to sponsor this report

About MarketsandMarkets

MarketsandMarkets is a research and consulting firm that publishes 120 market research reports per year. Each strategically analyzed report contains 250 pages of valuable market data, including more than 100 market data summary tables and in-depth, five-level segmentation for each of the products, services, applications, technologies, ingredients and stakeholders categories. Our reports also analyze about 200 patents, over 50 companies and micro markets that are mutually exclusive and collectively exhaustive. Browse all our 120 titles at http://www.marketsandmarkets.com.

    Contact:

    Ms. Sunita
    108, West 13th Street,
    Wilmington, DE, 19801
    County of New Castle
    Tel: +1-888-989-8004
    Email: sales@marketsandmarkets.com



'/>"/>
SOURCE Markets and Markets
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Global Experts Explore Entire Spectrum of Aids Vaccine Development
2. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
3. Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference
4. Touching 418 Billion Lives, Hepatitis Still Presents Significant Threat to Global Health
5. Touching 418 Million Lives, Hepatitis Still Presents Significant Threat to Global Health
6. Clinsys Clinical Research, Inc. Announces Key Hires, Rajagopalan Srinivasan, Ph.D, to Strengthen Global Biostatistics Service Offering and Christopher Gregory, Ph.D, to Scientific Affairs
7. Jazz Pharmaceuticals to Present at UBS Global Life Sciences Conference
8. A Large-Scale Research Project by a Dutch Consortium Addressing a Global Problem
9. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
10. Allos Therapeutics to Present at the 2007 UBS Global Life Sciences Conference
11. Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference to Webcast Millennium Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... 24, 2017   Bracket , a leading clinical ... addition of Jennifer Peters to its growing ... General Manager for the Scientific Services division. In this ... in Rater Training, Quality Assurance, and Electronic Clinical Outcomes ... skillset and demonstrated record building technology-based businesses in life ...
(Date:1/24/2017)... 2017  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), ... medicine, today announced positive efficacy results from the ... showed additional motor function improvement at 6-months and ... in AIS-A patients with complete cervical spinal cord ... motor function is critically important to patients with ...
(Date:1/24/2017)... , ... January 24, 2017 , ... ... solutions, announces the appointment of Steven F. McAllister as Executive Vice President and ... in both the U.S. and international markets. Beginning his career at Howmedica, Inc., ...
(Date:1/24/2017)... ... January 24, 2017 , ... Nanomedical Diagnostics , a ... fragment-based screening, will showcase its proprietary Field Effect Biosensing (FEB) technology ... conference in Washington, D.C. from Feb. 6 to Feb. 8. , Fragment-based drug ...
Breaking Biology Technology:
(Date:12/15/2016)... , Dec 15, 2016 ... Research and Markets has announced the ... their offering. The report forecasts the global military biometrics ... The report has been prepared based on an in-depth ... landscape and its growth prospects over the coming years. The report also ...
(Date:12/15/2016)... LONDON , Dec. 14, 2016 "Increase ... mobile biometrics market" The mobile biometrics market is expected ... USD 49.33 billion by 2022, at a CAGR of ... by factors such as the growing demand for smart ... mobile transactions. "Software component is expected to ...
(Date:12/8/2016)... , Dec. 8, 2016  Singulex, Inc., the leader ... technology, entered into a license and supply agreement with ... The agreement provides Singulex access to Thermo Scientific BRAHMS ... is used to diagnose systemic bacterial infection ... to aid in assessing the risk of ...
Breaking Biology News(10 mins):